Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19

BMJ. 2020 Oct 16;371:m3869. doi: 10.1136/bmj.m3869.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Comparative Effectiveness Research
  • Coronavirus Infections* / drug therapy
  • Coronavirus Infections* / epidemiology
  • Coronavirus Infections* / therapy
  • Drug Development* / organization & administration
  • Drug Development* / trends
  • Ethics, Research
  • Evidence-Based Medicine* / ethics
  • Evidence-Based Medicine* / methods
  • Evidence-Based Medicine* / trends
  • Humans
  • International Cooperation
  • Pandemics*
  • Pneumonia, Viral* / epidemiology
  • Pneumonia, Viral* / therapy
  • Quality Improvement*
  • Randomized Controlled Trials as Topic / methods
  • Randomized Controlled Trials as Topic / standards
  • Research Design / standards
  • SARS-CoV-2
  • Translational Medical Research

Supplementary concepts

  • COVID-19 drug treatment